Zoledronic Acid Dosing in Patients With Metastatic Breast Cancer
- PMID: 29192317
- DOI: 10.1001/jamaoncol.2017.0789
Zoledronic Acid Dosing in Patients With Metastatic Breast Cancer
Comment in
-
Zoledronic Acid Dosing in Patients With Metastatic Breast Cancer-Reply.JAMA Oncol. 2018 Apr 1;4(4):586. doi: 10.1001/jamaoncol.2017.3868. JAMA Oncol. 2018. PMID: 29192319 No abstract available.
Comment on
-
Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical Trial.JAMA Oncol. 2017 Jul 1;3(7):906-912. doi: 10.1001/jamaoncol.2016.6316. JAMA Oncol. 2017. PMID: 28125763 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical